StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock.
TherapeuticsMD Trading Up 2.7%
Shares of TXMD stock opened at $1.50 on Thursday. The stock has a 50 day simple moving average of $1.07 and a 200 day simple moving average of $1.13. TherapeuticsMD has a 1 year low of $0.70 and a 1 year high of $2.44.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company had revenue of $0.39 million for the quarter. TherapeuticsMD had a negative return on equity of 14.08% and a negative net margin of 207.77%.
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Read More
- Five stocks we like better than TherapeuticsMD
- How to trade using analyst ratings
- Top 4 ETFs for China Exposure After Tariff Relief
- What is a SEC Filing?
- Build a Complete Bond Portfolio With These 4 ETFs
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
